Drug Profile
Research programme: psoriasis foam therapies - Foamix/LEO Pharma
Alternative Names: Calcipotriol foamLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Foamix; LEO Pharma
- Class Antipsoriatics; Cyclohexanes; Cyclopropanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 09 Mar 2020 Foamix has been acquired by Menlo Therapeutics
- 05 Jun 2013 Discontinued - Preclinical for Psoriasis in Denmark (Topical)
- 01 Dec 2005 Preclinical trials in Psoriasis in Denmark (Topical)